New Delhi: The highly contagious Omicron variant could cause an “acute but short-lived” third wave of the COVID-19 pandemic, a team of researchers from the University of Cambridge has predicted. The team has also developed a COVID-19 India Tracker.
“It is likely that India will see a period of explosive growth in daily cases and a relatively short phase of rapid growth,” Bloomberg quoted Professor Paul Kattuman from the Judge Business School at the University of Cambridge in its report. ,
“New infections will start to rise in a few days, maybe this week,” he said, adding that it was difficult to predict how high the daily cases would be.
Researchers have observed a significant increase in infection rates across India. On December 24, the tracker rated six states in India as of “significant concern” with an adjusted growth rate of more than 5 per cent of new cases. According to the tracker, by December 26, it had expanded to 11 Indian states.
India gearing up to fight Omicron
India only 653. have reported omicron cases so far. Last week, the government approved booster shots for healthcare workers and people over the age of 60 and adolescents aged 15 to 18 years in the vaccination campaign. A total of eight COVID-19 vaccines have got emergency use authorization so far.
Two more vaccines, Corbevax and Kovovax, as well as Merck’s antiviral pill mollupiravir, were approved by the drug regulator on Tuesday.
On Tuesday, a day after the most new cases were reported in more than four months, Delhi on Tuesday closed theatres, schools and gyms, as well as banned public gatherings.
Bloomberg reported that the Cambridge India Tracker correctly called the peak of this devastating second wave in May and also predicted in August that India will see a slow burn in its COVID infection curve, as long as vaccination coverage is sufficient. Do not exceed.